|  Help  |  About  |  Contact Us

Publication : Combination therapy prevents amyloid-dependent and -independent structural changes.

First Author  Malthankar-Phatak G Year  2012
Journal  Neurobiol Aging Volume  33
Issue  7 Pages  1273-83
PubMed ID  21257234 Mgi Jnum  J:188220
Mgi Id  MGI:5439707 Doi  10.1016/j.neurobiolaging.2010.12.007
Citation  Malthankar-Phatak G, et al. (2012) Combination therapy prevents amyloid-dependent and -independent structural changes. Neurobiol Aging 33(7):1273-83
abstractText  Neuropathological features of Alzheimer's disease (AD) are recapitulated in transgenic mice expressing familial AD-causing mutations, but ectopic transgene overexpression makes it difficult to relate these abnormalities to disease pathogenesis. Alternatively, the APP/PS-1 double knock-in (DKI) mouse produces mutant amyloid precursor protein (APP) and presenilin-1 (PS-1) with normal levels and regulatory controls. Here, we investigated effects of amyloid on brain structure and neuroplasticity by vaccinating DKI mice with amyloid-beta starting at 8 months of age. At 14 months, vaccination blocked cerebral amyloid deposition and its attendant microglial activation. Neuropil abnormalities were pronounced only within plaques, and included circumscribed loss and dysmorphology of axons, dendrites, terminals and spines. Blockade of amyloid deposition restored neuropil integrity. Amyloid removal did not rescue reductions in the hippocampal neural progenitor and neuroblast populations, but adding 1 month of voluntary exercise to amyloid-beta vaccination markedly stimulated hippocampal neurogenesis. These results identify amyloid-dependent and -independent structural changes in the DKI mouse model of AD. Combining exercise with amyloid-directed immunotherapy produces greater restoration of brain structure and neuroplasticity than is achieved with either maneuver alone.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

Trail: Publication

0 Expression